Tricks of the TradeTrump's Second TermMy EconomyI've Always Wondered ...

Loading...

0:00
0% played
Support the fact-based journalism you rely on with a donation to Marketplace today. Give Now!
Stories Tagged as

Pharmaceutical drugs

The most popular over-the-counter decongestant doesn't work, FDA panel finds

by Stephanie Hughes
Sep 13, 2023
It replaced a decongestant that's a precursor to methamphetamine.
U.S. consumers bought bought nearly three hundred million packages of over the counter oral decongestants last year, according to the FDA.
Joe Raedle/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Congress to examine drug price hikes

by Erika Beras
Jan 29, 2019
Prescription drug prices have been rising over the past few years.
jorgeantonio/iStock/Getty Images Plus
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Big Pharma is betting big on cancer drugs

by Nancy Marshall-Genzer
Jan 3, 2019
Bristol-Myers Squibb announced Thursday that it’s going to acquire another drugmaker, Celgene. The deal is worth about $74 billion. The combined company will have nine products with sales of more than a billion dollars a year, including some blockbuster cancer drugs. The merger is a sign that Big Pharma is betting big on cancer medications. […]
pxhere
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Why some people are worried about drug patent protections in the new NAFTA

by Scott Tong
Oct 2, 2018
The trade agreement reached over the weekend between the U.S., Canada and Mexico includes longer intellectual property protection periods for the expensive class of drugs known as biologics.
LARS HAGBERG/AFP/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Generic Viagra floods the market. Here’s how Pfizer is reacting

by Dan Gorenstein
Jul 13, 2018
Pfizer hopes to run with its “little blue pill” as long as it can. That includes the time-honored strategy of launching its own generic.
Christopher Furlong/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

The FDA approves the first drug derived from cannabis

by Nancy Marshall-Genzer
Jun 28, 2018
Will this be the catalyst for big pharmaceutical companies to get into the pot business?
An assistant studies cannabis leaves in the Maripharma Laboratory in Rotterdam, Netherlands, in 2002.
Michel Porro/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Senate to scrutinize hospitals on low-income patient profits and spending

by Dan Gorenstein
Jun 19, 2018
This morning, a Senate committee checks in to see how the cuts to the so-called 340b program, which allows hospitals to buy drugs at a discount, are impacting hospitals and patients. Critics say there’s little evidence that hospitals used the savings to help patients. Click the audio player above to hear the full story. 
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE

For public good, not for profit.

Donate

FDA website to post names of drug makers blocking development of cheaper generics

by Dan Gorenstein
May 17, 2018
The FDA plans to unveil a website today naming pharmaceutical companies that have blocked the development of generic drugs by failing to provide samples to competitors. This public posting is part of FDA Commissioner Scott Gottlieb’s larger crackdown to, as he says, “end the shenanigans” by brand name drug companies. Click the audio player above […]
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE